Literature DB >> 4161643

Adrenergic blockade and the eye signs of thyrotoxicosis.

J M Sneddon, P Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4161643     DOI: 10.1016/s0140-6736(66)92881-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  Factors determining the potency of mydriatic drugs in man.

Authors:  S A Smith
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

Review 2.  Endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1972-02-05

3.  Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.

Authors:  N E Cartlidge; A L Crombie; J Anderson; R Hall
Journal:  Br Med J       Date:  1969-12-13

4.  Dysthyroid eye disease. A trial of guanethidine eye drops.

Authors:  A N Bowden; F C Rose
Journal:  Br J Ophthalmol       Date:  1969-04       Impact factor: 4.638

5.  Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.

Authors:  A L Crombie; A A Lawson
Journal:  Br J Ophthalmol       Date:  1968-08       Impact factor: 4.638

6.  Thyroid and adrenal relationships.

Authors:  V Parsons; I Ramsay
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

7.  Management of endocrine ophthalmopathy.

Authors: 
Journal:  Br Med J       Date:  1968-09-07

8.  Action of dopamine on the human iris.

Authors:  A S Spiers; D B Calne
Journal:  Br Med J       Date:  1969-11-08

9.  Comparison of propranolol and practolol in the management of hyperthyroidism.

Authors:  L E Murchison; P D Bewsher; M I Chesters; W R Ferrier
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

Review 10.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.